Data-driven Intelligence on the FDA

featuresBlog

Today Show Hypes Medical Device Reprocessing Safety Issues

A recent segment on the Today show highlighted public concerns regarding hospital acquired infections – specifically, those that can be contracted from medical devices and surgical instruments. The report presented the case that even if proper sterilization processes are followed, there remains a strong chance that surgical equipment will be contaminated with blood, tissue, and [...]
Tue, 10 Apr 2012

Proposals to Speed-Up Drug Approvals: Not Created Equal

An important part of the 2012 user fee reauthorization cycle is Congressional efforts to push FDA toward approving drugs and biologics more rapidly. Most of industry and a large number of patient groups agree. Proposals to speed up FDA are already in play. Since these proposals have a common purpose, it is easy to think of them [...]
Tue, 03 Apr 2012

FDA Progress “At Risk:” An Update on Funding and a Call to Action

FDA Matters’ State of the FDA—January 2012 identified agency funding as the greatest threat to the FDA’s future.  The agency received a very small increase in FY 12 appropriated funding, reflecting the severe budgetary pressure on all U.S. federal agencies. That pressure continues and FDA faces potential cuts in FY 13 (starting October 1, 2012). Advocacy by the Alliance [...]
Thu, 29 Mar 2012

mGet the latest on FDA intelligence


Email address:
Sponsors / Friends
  • Process automation for the regulated markets

    Process automation for the regulated markets

  • Expert Briefings

    Webinar and audio conference education in the FDA regulatory industry

  • Laboratory Retriever

    Laboratory and Regulatory Resources and News

  • FDA and Medical device business news

    FDA and Medical device business news and jobs for the medical device industry

  • Regulatory Compliance

    Facilitating Regulatory Compliance Worldwide.